Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Arevitalize vs Medsol RX

Dr. Arevitalize
Graded #225

Higher grade

vs+4.200000000000003
Medsol RX
Graded #306

Lower grade

The verdict

Dr. Arevitalize takes it — 65.2/100 to 61/100.

Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide fr

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedsol RX +6
39
45
Dose & formulationDr. Arevitalize +11
75
64
Clinical oversightMedsol RX +8
71
79
Labs & monitoringDr. Arevitalize +35
88
53
FulfillmentMedsol RX +11
72
83
Contract termsDr. Arevitalize +14
55
41
Dr. Arevitalize · left barMedsol RX · right bar

The numbers

MetricDr. ArevitalizeMedsol RX
WeighScore65.2/10061/100
GradeCC
Scorecard rank#225#306
Semaglutide$319/mo (compounded)$209/mo (compounded)
Tirzepatide$359/mo (compounded)$250/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Dr. Arevitalize

Graded #225 · C

Strengths

  • Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
  • Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
  • LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
  • Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and prescribing clinician are not named on the site
  • State availability is not published on the site
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard